Cite
CLINICAL OUTCOMES TO 4 YEARS IN PATIENTS IMPLANTED WITH BIOABSORBABLE POLYMER SYNERGY VERSUS PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: THE EVOLVE II RANDOMIZED TRIAL.
MLA
Jobe, Robert, et al. “Clinical Outcomes to 4 Years in Patients Implanted with Bioabsorbable Polymer Synergy Versus Permanent Polymer Everolimus-Eluting Stents: The Evolve Ii Randomized Trial.” Journal of the American College of Cardiology (JACC), vol. 71, Mar. 2018, p. A1018. EBSCOhost, https://doi.org/10.1016/S0735-1097(18)31559-6.
APA
Jobe, R., Windecker, S., Loli, A., Mego, D., Ando, K., Muramatsu, T., Stammen, F., Curtis, M., Helqvist, S., Christen, T., Allocco, D., Meredith, I., & Kereiakes, D. (2018). Clinical Outcomes to 4 Years in Patients Implanted with Bioabsorbable Polymer Synergy Versus Permanent Polymer Everolimus-Eluting Stents: The Evolve Ii Randomized Trial. Journal of the American College of Cardiology (JACC), 71, A1018. https://doi.org/10.1016/S0735-1097(18)31559-6
Chicago
Jobe, Robert, Stephan Windecker, Akil Loli, David Mego, Kenji Ando, Toshiya Muramatsu, Francis Stammen, et al. 2018. “Clinical Outcomes to 4 Years in Patients Implanted with Bioabsorbable Polymer Synergy Versus Permanent Polymer Everolimus-Eluting Stents: The Evolve Ii Randomized Trial.” Journal of the American College of Cardiology (JACC) 71 (March): A1018. doi:10.1016/S0735-1097(18)31559-6.